×
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial (vol 396, pg 1979, 2020)
Ramasamy MN., Minassian AM., Ewer KJ.
Type
Journal article
Journal
LANCET
Publication Date
2021
Volume
397
Pages
1350 - 1350